"If an NHS trust proposed today that it was going to introduce Viagra sales reps into men's genitourinary wards, or reps for walking aids to orthopaedic wards, the very least you'd expect would be some stout resistance. It is a measure of the strength of the association between "motherhood" and "buying stuff" that the presence of commercial representatives on maternity wards has been tolerated for so long."[more inside]
The Geography of Abortion Access - Forty years ago Tuesday, the Supreme Court ushered in legal abortion for American women when it decided in Roe v. Wade. Today, states—particularly in the South and Midwest—are eroding that right by legislating hundreds of provisions intended to impede access with burdensome obstacles. To understand more fully the complex state of access to abortion services in America, The Daily Beast identified and confirmed the location of the country’s remaining 724 clinics and calculated the distance from every part of the country to its closest clinic. (more)
Consumer Reports May 2012: What to reject when you're expecting (10 procedures to think twice about during your pregnancy; 10 things you should do during your pregnancy; 5 things you should do before you become pregnant). Mentioned in particular is the conclusion found in a federal study: Babies Take Longer To Come Out Than They Did In Grandma's Day."One big implication: Today's obstetricians may be rushing to do cesarean sections too soon because they're using an out-of-date yardstick for how long a 'normal; labor should take... The definition of a 'normal' labor — the range of times when a woman in labor reaches certain milestones — was laid down in the 1950s. Contemporary obstetricians still use that 'labor curve.'"
"What Every Woman Should Know" by Susie Cagle on Cartoon Movement provides an illustrated investigation of "crisis pregnancy centers" like First Resort. (via)
Progesterone caproate injections have been used to reduce the likelihood of premature births in at-risk pregnant women for years. Up until now, the drug was custom-compounded by wholesale and specialist pharmacies, legally, but without federal approval. These injections cost between $5 and $15 a dose and were regularly reimbursed by insurance companies and Medicaid. Last month, the FDA announced their approval of a commercially produced version of the compound, to be marketed under the brand name Makena by a company called KV Pharmaceuticals. No stranger to controversy and trouble, KV barely survived a rash round of layoffs and wrongful termination lawsuits. Their former chief executive now faces criminal charges surrounding the company's failure to notify the FDA that they were producing oversized morphine tablets. (He could also do for a shave, it appears.) Now, KV has announced that the new drug will be available at a cost of $1,500 per dose, bringing the total pregnancy term cost of treatment to $25,000-$30,000, from its former cost of $250-$300, a 100-fold increase—but it gets worse... [more inside]
It's Only Rape if They Say So House Republicans decide to fight abortion access by redefining rape.